| Primary |
| Drug Use For Unknown Indication |
28.9% |
| Product Used For Unknown Indication |
22.9% |
| Schizophrenia |
13.2% |
| Depression |
5.5% |
| Bipolar Disorder |
4.8% |
| Psychotic Disorder |
4.8% |
| Ill-defined Disorder |
2.7% |
| Anxiety |
2.6% |
| Schizoaffective Disorder |
1.9% |
| Schizophrenia, Paranoid Type |
1.8% |
| Insomnia |
1.6% |
| Hypertension |
1.3% |
| Abnormal Behaviour |
1.2% |
| Attention Deficit/hyperactivity Disorder |
1.1% |
| Agitation |
1.1% |
| Dementia |
1.0% |
| Aggression |
1.0% |
| Autism |
1.0% |
| Self Injurious Behaviour |
0.9% |
| Drug Exposure During Pregnancy |
0.9% |
|
| Weight Increased |
19.6% |
| Diabetes Mellitus |
12.1% |
| Type 2 Diabetes Mellitus |
9.1% |
| Suicide Attempt |
9.0% |
| Self Injurious Behaviour |
6.1% |
| Tachycardia |
4.7% |
| Somnolence |
4.2% |
| Tardive Dyskinesia |
3.6% |
| Tremor |
3.3% |
| Treatment Noncompliance |
3.1% |
| Vomiting |
3.0% |
| Thrombocytopenia |
2.9% |
| Death |
2.9% |
| Suicidal Ideation |
2.6% |
| Weight Decreased |
2.4% |
| Off Label Use |
2.3% |
| White Blood Cell Count Decreased |
2.3% |
| Neutropenia |
2.3% |
| Rhabdomyolysis |
2.3% |
| Pulmonary Embolism |
2.2% |
|
| Secondary |
| Schizophrenia |
18.5% |
| Product Used For Unknown Indication |
18.4% |
| Drug Use For Unknown Indication |
13.0% |
| Depression |
9.4% |
| Bipolar Disorder |
7.4% |
| Psychotic Disorder |
5.4% |
| Anxiety |
4.9% |
| Insomnia |
3.0% |
| Schizophrenia, Paranoid Type |
3.0% |
| Schizoaffective Disorder |
2.7% |
| Constipation |
1.9% |
| Attention Deficit/hyperactivity Disorder |
1.8% |
| Hypertension |
1.8% |
| Ill-defined Disorder |
1.7% |
| Aggression |
1.4% |
| Agitation |
1.2% |
| Schizophrenia, Disorganised Type |
1.2% |
| Sleep Disorder |
1.1% |
| Autism |
1.1% |
| Drug Exposure During Pregnancy |
1.0% |
|
| Weight Increased |
24.5% |
| Type 2 Diabetes Mellitus |
13.0% |
| Diabetes Mellitus |
6.5% |
| Somnolence |
5.8% |
| Treatment Noncompliance |
4.8% |
| Weight Decreased |
4.5% |
| Tremor |
3.9% |
| Vomiting |
3.7% |
| Tardive Dyskinesia |
3.6% |
| Rhabdomyolysis |
3.2% |
| Suicide Attempt |
3.1% |
| Thrombocytopenia |
3.1% |
| White Blood Cell Count Decreased |
3.0% |
| Sedation |
2.9% |
| Suicidal Ideation |
2.7% |
| Urinary Retention |
2.6% |
| Schizophrenia |
2.4% |
| Psychotic Disorder |
2.3% |
| Urinary Tract Infection |
2.2% |
| Neuroleptic Malignant Syndrome |
2.2% |
|
| Concomitant |
| Depression |
17.8% |
| Schizophrenia |
12.9% |
| Bipolar Disorder |
11.9% |
| Product Used For Unknown Indication |
11.0% |
| Anxiety |
7.4% |
| Drug Use For Unknown Indication |
5.6% |
| Insomnia |
5.4% |
| Sleep Disorder |
4.3% |
| Hypertension |
3.1% |
| Pain |
3.0% |
| Psychotic Disorder |
2.8% |
| Prophylaxis |
2.4% |
| Diabetes Mellitus |
2.1% |
| Schizoaffective Disorder |
1.9% |
| Attention Deficit/hyperactivity Disorder |
1.8% |
| Affective Disorder |
1.4% |
| Constipation |
1.4% |
| Agitation |
1.3% |
| Schizophrenia, Paranoid Type |
1.3% |
| Smoking Cessation Therapy |
1.2% |
|
| Type 2 Diabetes Mellitus |
32.4% |
| Weight Increased |
12.7% |
| Pancreatitis |
7.5% |
| Diabetes Mellitus |
5.0% |
| Vomiting |
5.0% |
| Tardive Dyskinesia |
4.1% |
| Weight Decreased |
3.8% |
| Type 1 Diabetes Mellitus |
3.4% |
| Suicidal Ideation |
3.0% |
| Suicide Attempt |
2.4% |
| Somnolence |
2.4% |
| Tremor |
2.4% |
| Obesity |
2.3% |
| Schizophrenia |
2.2% |
| Urinary Tract Infection |
2.1% |
| White Blood Cell Count Decreased |
2.1% |
| Death |
2.0% |
| Vision Blurred |
1.8% |
| Overdose |
1.8% |
| Rash |
1.7% |
|
| Interacting |
| Schizophrenia |
16.5% |
| Depression |
12.6% |
| Drug Use For Unknown Indication |
12.0% |
| Product Used For Unknown Indication |
9.9% |
| Post-traumatic Stress Disorder |
6.2% |
| Anxiety |
5.4% |
| Obsessive-compulsive Disorder |
4.8% |
| Schizoaffective Disorder |
4.8% |
| Paranoia |
3.2% |
| Diabetes Mellitus |
2.7% |
| Acute Lymphocytic Leukaemia |
2.6% |
| Smoking Cessation Therapy |
2.6% |
| Attention Deficit/hyperactivity Disorder |
2.2% |
| Dementia |
2.2% |
| Hypertension |
2.2% |
| Agitation |
2.1% |
| Mania |
2.1% |
| Psychotic Disorder |
2.1% |
| Dementia Alzheimer's Type |
1.9% |
| Neuralgia |
1.9% |
|
| Drug Interaction |
17.9% |
| Parkinsonism |
10.7% |
| Leukopenia |
7.1% |
| Mania |
7.1% |
| Sedation |
7.1% |
| Obsessive-compulsive Disorder |
4.5% |
| Paranoia |
4.5% |
| Polydipsia |
4.5% |
| Hepatic Encephalopathy |
3.6% |
| Myocardial Infarction |
3.6% |
| Salivary Hypersecretion |
3.6% |
| Torticollis |
3.6% |
| Tremor |
3.6% |
| Urinary Tract Obstruction |
3.6% |
| Cognitive Disorder |
2.7% |
| Inappropriate Antidiuretic Hormone Secretion |
2.7% |
| Neuropathy Peripheral |
2.7% |
| Thrombocytopenia |
2.7% |
| Weight Increased |
2.7% |
| Alcoholism |
1.8% |
|
